ReviewInternational journal of molecular sciences2023

The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer's Disease Treatment.

Majid Ghareghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.